WebApr 20, 2024 · London, 20 April 2024 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today confirms it has received preliminary approval from the US Federal Trade Commission (FTC) and will now work towards closing its acquisition of Custopharm Inc. from Water Street Healthcare Partners, as previously … WebApr 19, 2024 · "Hikma’s acquisition of Custopharm's TCA business could have caused significant harm for patients who use TCA to treat severe skin conditions, allergies, and inflammation," Holly Vedova ...
Hikma confirms FTC preliminary approval for Custopharm
Webcompetition by eliminating future competition between Hikma and Custopharm in the market for injectable TCA thereby (1) increasing the likelihood that the combined entity would forego the launch of Hikma’s injectable TCA product in development; and (2) increasing the likelihood that the combined entity would delay, reduce, or eliminate the WebApr 12, 2024 · Hikma, which means “wisdom” in Arabic, was founded in Jordan in 1978 and supplies various generic drugs including anaesthetics, pain medications, sedatives, neuromuscular blocking agents and anti-infectives. ... In April 2024, the company completed the acquisition of California-based Custopharm in a deal valued at $425 million, as part of ... finally we meet in person
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceut
WebLondon — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of generic injectable medicines in the US, today … WebApr 20, 2024 · Hikma Pharmaceuticals ( OTCPK:HKMPF) ( OTCPK:HKMPY ) said it received preliminary approval from the U.S. Federal Trade Commission for its its acquisition of Custopharm from Water Street Healthcare ... WebMay 4, 2024 · Pursuant to an agreement dated September 27, 2024, Hikma proposes to acquire Custopharm in a transaction valued at approximately $375 million. As part of the … gse trays